Actively Recruiting
Cohort Follow-up of Epidemic and Neuroimaging for Patients During the 1st Wave of the COVID-19 in China
Led by First Affiliated Hospital Xi'an Jiaotong University · Updated on 2023-02-27
600
Participants Needed
1
Research Sites
191 weeks
Total Duration
On this page
Sponsors
F
First Affiliated Hospital Xi'an Jiaotong University
Lead Sponsor
N
Nuclear 215 Hospital of Shaanxi Province
Collaborating Sponsor
AI-Summary
What this Trial Is About
Our main objective is to analyze the development of physical impact, mental health and blood profile over follow-up time during the 1st wave of the COVID-19. Besides, we aim to establish a database of post-COVID-19 based on simultaneous cortico-spinal magnetic resonance imaging data to identify high-risk patients with long COVID and prevent the neurological symptoms evolution, optimize the tactics of management in China.
CONDITIONS
Official Title
Cohort Follow-up of Epidemic and Neuroimaging for Patients During the 1st Wave of the COVID-19 in China
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed diagnosis of mild COVID-19 according to WHO criteria
- Confirmed diagnosis of moderate COVID-19 according to WHO criteria
- Healthy people who have not had COVID-19
You will not qualify if you...
- History of central nervous system diseases such as mental disorder, degenerative diseases, tumors, or trauma
- Participants with contraindications for MRI studies
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
First Affiliated Hospital of Xian Jiaotong University
Xi'an, Shaanxi, China, 710061
Actively Recruiting
Research Team
M
Ming Zhang, PhD
CONTACT
X
Xuan Niu, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here